Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The first ingredient, tirzepatide , is a dual GIP/GLP-1 receptor agonist originally developed by Eli Lilly and approved by the FDA under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
JPEN J Parenter.Enteral Nutr 1988;12(1):29-34
121123 Consequently, drug-metabolizing enzyme-mediated DDIs, typically involving competition for the same CYP binding site with another drug, are uncommon in peptide drug-related DDIs
Frantz C, Stewart KM, Weaver VM
It was first isolated in 1973 by biochemist Dr
US$ 19.98
US$ 20.33
US$ 25.70
US$ 27.14
US$ 21.82
US$ 26.94
US$ 28.85
